Focal liver lesions (FFLs) evaluated using contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CECT) may have the same or similar findings or substantial discrepant findings. Such phenomenon can be found in two performances of CEUS that the second performance of CEUS conducted shortly following the initial performance of CEUS. Discrepancy of two performances of CEUS for FFLs occurring in the same patient at a short internal has not been well addressed, which raises challenge for CEUS for the evaluation of FFLs. In this case study, such phenomenon is illustrated and implication is obtained.
TakahashiM, MaruyamaH, ShimadaT, KamezakiH, SekimotoT, KanaiF,et al.Characterization of hepatic lesions (≤30mm) with liver-specific contrast agents: A comparison between ultrasound and magnetic resonance imaging, Eur J Radiol. 2013;82(1):75–84.
2.
QuaiaE. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: The added diagnostic value of contrast-enhanced ultrasound, Abdom Imaging. 2012;37(4):580–90.
3.
LaumonierH, CailliezH, BalabaudC, PossentiL, Zucman-RossiJ, Bioulac-SageP,et al.Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: Correlation with MRI findings, AJR Am J Roentgenol. 2012;199(2):341–8.
4.
LekhtI, GulatiM, NayyarM, KatzMD, Ter-OganesyanR, MarxM,et al. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone, Abdom Radiol (NY). 2016;41(8):1511–21.
5.
ShiozawaK, WatanabeM, IkeharaT, MatsukiyoY, KogameM, KikuchiY,et al. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer, J Clin Ultrasound. 2017;45(3):138–44.
6.
WangP, NieF, DongT, WangG, WangL, FanX. Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma, Clin Hemorheol Microcirc. 2022;80(2):97–106.
7.
ChenY, ZhuY, ChenK, WangH, ZhangW, BaoJ, WangW. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis, Clin Hemorheol Microcirc. 2021;79(2):293–309.
8.
ZuoD, YangK, WuS. Diagnostic performance of intravascular perfusion based contrast-enhanced ultrasound LI-RADS in the evaluation of hepatocellular carcinoma, Clin Hemorheol Microcirc. 2021;78(4):429–437.
9.
LeeMW, KimYJ, ParkHS, YuNC, JungSI, KoSY,et al. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: Factors affecting sonographic detection, AJR Am J Roentgenol.W. 2010;194(5):396–400.
10.
KimPN, ChoiD, RhimH, RhaSE, HongHP, LeeJ,et al. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤3cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: A multicenter prospective study to assess factors affecting ultrasound visibility, J Vasc Interv Radiol. 2012;23(5):627–34.
11.
SchernthanerRE, HarounRR, DuranR, LeeH, SahuS, SohnJH,et al. Improved visibility of metastatic disease in the liver during intra-arterial therapy using delayed arterial phase cone-beam CT, Cardiovasc Intervent Radiol. 2016;39(10):1429–37.
12.
YangWY, ParkHS, KimYJ, YuMH, JungSI, JeonHJ. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI, J Clin Ultrasound. 2017;45(9):542–50.
13.
CatalanoO, SandomenicoF, ValloneP, SetolaSV, GranataV, FuscoR,et al. Contrast-enhanced ultrasound in the assessment of patients with indeterminate abdominal findings at positron emission tomography imaging, Ultrasound Med Biol. 2016;42(11):2717–23.
14.
LiR, TangCL, CaiP, MaKS, ZhangXH, DingSY, et al. Comparison of CT and contrast-enhanced ultrasound findings in hepatic angiomyolipoma with pathological correlations, Abdom Radiol (NY). 2016;41(2):248–56.
PaulSB, DhamijaE, GamanagattiSR, SreenivasV, YadavDP, JainS,et al. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography, Diagn Interv Imaging. 2017;98(3):253–60.
17.
LiuM, LinMX, LuMD, XuZF, ZhengKG, WangW,et al.Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST, Eur Radiol. 2015;25(8):2502–11.
18.
KaufmannS, SchulzeM, SpiraD, HorgerM. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: A preliminary report, Acta Radiol. 2016;57(1):8–12.
19.
QuP, YuX, LiangP, ChengZ, HanZ, LiuF, YuJ. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: Comparison with contrast-enhanced magnetic resonance imaging, Ultrasound Med Biol. 2013;39(9):1571–79.
20.
DietrichCF, NolsøeCP, BarrRG, BerzigottiA, BurnsPN, CantisaniV,et al. Guidelines and good clinical practice recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS, Ultrasound Med Biol. 2020;46(10):2579–604.
